Mayara I. G. Azevedo

Mayara I. G. Azevedo

Auto-generated profile, based on publicly available information

Mayara I. G. Azevedo

Universidade de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2026 in Fungal Biology Reviews
Verified
Journal Article
Open access
JNJoão Neves-Da-Rocha
João Neves-Da-Rocha
MLMarcos E.R. Lopes
Marcos E.R. Lopes
MAMayara I.G. Azevedo
Mayara I.G. Azevedo
MPMonise F. Petrucelli
Monise F. Petrucelli
MSMaria J. Santos-Saboya
Maria J. Santos-Saboya
NMNilce M. Martinez-Rossi
Nilce M. Martinez-Rossi

1 January 2026 in Genetics and Molecular Biology
Verified
Journal Article
Open access
MAMayara I. G. Azevedo
Mayara I. G. Azevedo
MSMaria J. Santos-Saboya
Maria J. Santos-Saboya
JNJoão Neves-da-Rocha
João Neves-da-Rocha
MPMonise Petrucelli
Monise Petrucelli
NMNilce M. Martinez-Rossi
Nilce M. Martinez-Rossi
ARAntonio Rossi
Antonio Rossi
Sertraline, a selective serotonin reuptake inhibitor, is a widely used antidepressant. In recent decades, research has revealed its potential for drug repurposing, demonstrating various biological activities beyond psychiatric applications, including antifungal, antibacterial, antitumor, anthelmintic, and leishmanicidal effects. This review explores the antifungal potential of sertraline and its possible mechanisms of action against fungal cells, highlighting similarities with its effects in higher eukaryotes. We examine the effects of sertraline on (1) gene expression pathways, (2) lipid and carbohydrate metabolism, (3) membrane function, (4) stress response, and (5) alternative splicing modulation. Finally, we discuss future perspectives on the use of sertraline as an antifungal agent.